English Portal - Bullets list https://www.cea.fr/english/Pages/european-projects-newsletter/bioeconomy-and-health.aspx CEA is a French government-funded technological research organisation. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world. en-US https://www.cea.fr/PublishingImages/cea.jpg English Portal - Bullets list https://www.cea.fr/english ABIRISK for safe and effective biotherapies https://www.cea.fr/english/Pages/News/-Abirisk-for-safe-and-effective-biotherapies.aspx Increasing numbers of medicines are molecules that are of biological origin. Unfortunately, such medicines can induce an undesirable response from the immune system. How can we measure such a response? What mechanisms are governing it? Answers to such questions have been provided by the ambitious European Project Abirisk, supported by the Innovative Medicines Initiative Health & life sciences ; Diagnosis and innovative treatment ; Pharmacology ; Diseases Journalists ; Researchers ; general public Paris-Saclay News ; Newsletter ; CEA Research News ; Europe ; European & international partnerships H2020;bioeconomy and health;medicine; Thu, 13 Sep 2018 10:00:00 GMT A NEW DEAL for a disruptive progress against inflammatory bowel diseases https://www.cea.fr/english/Pages/News/A-NEW-DEAL-for-a-disruptive-progress-against-inflammatory-bowel-diseases.aspx The European project NEW DEAL, coordinated by the CEA, aims to develop a highly selective and local therapy based on siRNA and using nanostructures carriers with an improved efficacy and safety profile for all inflammatory bowel diseases (IBD) patients. It could improve efficacity and safety for all inflammatory bowel diseases (IBD) patients. Health & life sciences ; Diagnosis and innovative treatment ; Biotechnology ; Diseases ; Autoimmune diseases ; Genetic diseases Journalists ; Researchers ; general public ; Companies BIG News ; Newsletter ; European & international partnerships ; CEA Research News IBD;inflammatory bowel diseases;nanotherapy;crohn;H2020;bioeconomy and health; Tue, 10 Apr 2018 10:00:00 GMT Biocapan provides an invisibility cape for functioning transplants https://www.cea.fr/english/Pages/News/Biocapan-provides-an-invisibility-cape-for-functioning-transplants.aspx The H2020 Biocapan project, coordinated by the CEA, is developing an innovative cell therapy to supplement a poorly functioning pancreas in patients with type 1 diabetes. The two major goals of this therapy - which involves the use of a revolutionary biocapsule - are to prevent transplanted cells from being rejected and to enable them to perform their function. This will enhance patients’ lives, in particular by eliminating the need for immunosuppressive treatments, which often have severe side-effects. Health & life sciences ; Diagnosis and innovative treatment ; Gene and cell therapy ; Cellular mechanisms ; Genetic diseases Journalists ; general public ; Researchers Grenoble CEA Research News ; Newsletter ; News ; European & international partnerships health;H2020;diabetic;bioeconomy;bioeconomy and health; Fri, 02 Feb 2018 17:00:00 GMT EUNCL facilities support nanomedicine development in Europe https://www.cea.fr/english/Pages/News/EUNCL-facilities-support-nanomedicine-development-in-Europe.aspx The European project EUNCL is dedicated to perform and standardize pre-clinical characterization of nanomaterials for medical applications funded under Horizon 2020 Framework Programme. EUNCL also serves as a European knowledge base for researchers and industry ensuring that this knowledge is documented in Europe for the benefit of the European economy, healthcare systems and patients. Health & life sciences ; Nanomedicine ; Diagnosis and innovative treatment ; Characterisation ; Tools & research instruments Journalists ; general public ; Researchers Grenoble News ; Newsletter ; CEA Research News ; European & international partnerships platform;H2020;bioeconomy and health;pre-clinical;Medical; Mon, 27 Nov 2017 11:00:00 GMT From Venoms to innovative Drugs with VENOMICS https://www.cea.fr/english/Pages/News/From-Venoms-to-innovative-Drugs-with-VENOMICS.aspx Based on the study of two hundred poisonous animals, the European project VENOMICS managed to reproduce a bank of 3,616 “natural” toxins compatible with high throughput screening. VENOMICS demonstrated that animal toxins are hundred times more effective in identifying drug candidates than the usual banks of artificial molecules. Health & life sciences ; Diagnosis and innovative treatment ; Pharmacology ; Structural biology ; High-throughput screening Journalists ; general public ; Researchers Joliot News ; Newsletter ; CEA Research News ; European & international partnerships vaccine;Animal;bioeconomy and health;venoms; Mon, 19 Jun 2017 08:00:00 GMT ISOTOPICS: The renewal of isotopic labeling for strengthening European therapeutic innovation https://www.cea.fr/english/Pages/News/isotopics-renewal-isotopic-labeling-strengthening-European-therapeutic-innovation.aspx ISOTOPICS is a European research project which aims at the development of new methods for the chemical labeling of drug candidates to streamline drug innovation and to decrease drug attrition. Health & life sciences ; Biotechnology ; Diagnosis and innovative treatment ; Pharmacology ; Biomarkers ; Molecular mechanisms ; Chemistry general public ; Journalists ; Researchers IBITECS News ; Newsletter ; European & international partnerships chemistry;Molecular mechanisms;Biomarkers;pharmacology;Biotechnology;Health & life sciences;Drug Resistance;isotopics;Diagnosis and innovative treatment;bioeconomy and health; Thu, 02 Feb 2017 11:00:00 GMT